Low-cap pot: Small cannabis companies
23 No. of Symbols
−10.38USD
−44.60 MUSD
10.38 M
About Corbus Pharmaceuticals Holdings, Inc.
Sector
CEO
Yuval Cohen
Headquarters
Norwood
Website
Employees (FY)
19
Founded
2009
ISIN
US21833P3010
FIGI
BBG0078PJKQ7
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its products include candidate, Lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded in April 2009 and is headquartered in Norwood, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where CRBP is featured.
Frequently Asked Questions
The current price of CRBP is 36.56 USD — it has decreased by 1.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Corbus Pharmaceuticals Holdings, Inc. stocks are traded under the ticker CRBP.
Corbus Pharmaceuticals Holdings, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CRBP stock is 4.45% volatile and has beta coefficient of 1.06. Check out the list of the most volatile stocks — is Corbus Pharmaceuticals Holdings, Inc. there?
One year price forecast for Corbus Pharmaceuticals Holdings, Inc. has a max estimate of 58.00 USD and a min estimate of 52.00 USD.
CRBP earnings for the last quarter are −2.27 USD whereas the estimation was −2.06 USD which accounts for −10.19% surprise. Estimated earnings for the next quarter are −2.16 USD. See more details about Corbus Pharmaceuticals Holdings, Inc. earnings.
Corbus Pharmaceuticals Holdings, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 150.00 K USD. In the next quarter revenue is expected to reach 200.00 K USD.
Yes, you can track Corbus Pharmaceuticals Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
CRBP stock has fallen by 4.04% compared to the previous week, the month change is a 7.44% fall, over the last year Corbus Pharmaceuticals Holdings, Inc. has showed a 203.65% increase.
CRBP net income for the last quarter is −8.02 M USD, while the quarter before that showed −10.05 M USD of net income which accounts for 20.21% change. Track more Corbus Pharmaceuticals Holdings, Inc. financial stats to get the full picture.
Today Corbus Pharmaceuticals Holdings, Inc. has the market capitalization of 389.92 M, it has increased by 7.21% over the last week.
No, CRBP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CRBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Corbus Pharmaceuticals Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 19.00 employees. See our rating of the largest employees — is Corbus Pharmaceuticals Holdings, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Corbus Pharmaceuticals Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Corbus Pharmaceuticals Holdings, Inc. stock shows the neutral signal. See more of Corbus Pharmaceuticals Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Corbus Pharmaceuticals Holdings, Inc. future price: according to them, CRBP price has a max estimate of 58.00 USD and a min estimate of 52.00 USD. Read a more detailed Corbus Pharmaceuticals Holdings, Inc. forecast: see what analysts think of Corbus Pharmaceuticals Holdings, Inc. and suggest that you do with its stocks.